Soleno Therapeutics, Inc. (SLNO) Misses Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts SLNO Hot Sheet
Join SI Premium – FREE
Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.88), $0.17 worse than the analyst estimate of ($0.71).
For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Vertiv to acquire microgrid firm UtilityInnovation Group for $1.45B
- Stitch Fix, Inc. (SFIX) PT Lowered to $4 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
